Total Payments
$2,747
2024 Payments
$254.27
Companies
14
Transactions
112
Medicare Patients
1,167
Medicare Billing
$161,545
Payment Breakdown by Category
Food & Beverage$2,747 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,747 | 112 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,402 | 63 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $410.70 | 10 | $0 (2024) |
| Gilead Sciences, Inc. | $183.07 | 5 | $0 (2023) |
| CSL Behring | $172.61 | 11 | $0 (2020) |
| PFIZER INC. | $142.06 | 9 | $0 (2024) |
| Allergan, Inc. | $133.97 | 1 | $0 (2020) |
| Boston Scientific Corporation | $123.91 | 1 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $52.12 | 4 | $0 (2019) |
| Chiesi USA, Inc. | $33.93 | 2 | $0 (2024) |
| PORTOLA PHARMACEUTICALS, INC. | $27.93 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $254.27 | 13 | AstraZeneca Pharmaceuticals LP ($99.15) |
| 2023 | $265.75 | 9 | Gilead Sciences, Inc. ($157.93) |
| 2022 | $479.80 | 21 | Janssen Pharmaceuticals, Inc ($354.80) |
| 2021 | $716.83 | 31 | Janssen Pharmaceuticals, Inc ($647.38) |
| 2020 | $214.23 | 6 | Allergan, Inc. ($133.97) |
| 2019 | $668.29 | 21 | Janssen Pharmaceuticals, Inc ($308.73) |
| 2018 | $75.70 | 6 | CSL Behring ($37.41) |
| 2017 | $72.41 | 5 | CSL Behring ($30.35) |
All Payment Transactions
112 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/08/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $66.79 | General |
| Category: Rare Disease | ||||||
| 08/23/2024 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: HEMATOLOGY | ||||||
| 08/20/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/14/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/18/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/12/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Rare Disease | ||||||
| 05/10/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/08/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/02/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/18/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $14.86 | General |
| 04/08/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Rare Disease | ||||||
| 01/30/2024 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $14.09 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/25/2023 | Mindray DS USA, Inc. | TE7 MAX (Device), TE X | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: ULTRASOUND | ||||||
| 10/24/2023 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: COVID-19 | ||||||
| 10/11/2023 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: COVID-19 | ||||||
| 09/20/2023 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: COVID-19 | ||||||
| 07/12/2023 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $19.84 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/11/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/13/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/08/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/17/2023 | PFIZER INC. | ELIQUIS (Drug), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/14/2022 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Rare Disease | ||||||
| 09/13/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $10.36 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/07/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $10.36 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 153 | 159 | $197,782 | $21,861 |
| 2022 | 9 | 245 | 264 | $215,030 | $28,255 |
| 2021 | 5 | 435 | 456 | $580,283 | $65,787 |
| 2020 | 5 | 334 | 346 | $432,736 | $45,642 |
Total Patients
1,167
Total Services
1,225
Medicare Billing
$161,545
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 88 | 94 | $117,839 | $13,761 | 11.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 24 | 24 | $44,244 | $4,167 | 9.4% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 41 | 41 | $35,699 | $3,933 | 11.0% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 77 | 79 | $120,715 | $12,718 | 10.5% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 29 | 29 | $30,614 | $3,079 | 10.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 14 | 14 | $27,189 | $2,882 | 10.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 20 | 22 | $7,744 | $2,805 | 36.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 31 | 32 | $8,000 | $2,600 | 32.5% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 21 | 21 | $12,105 | $1,323 | 10.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 14 | 14 | $4,312 | $1,289 | 29.9% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 26 | 27 | $3,051 | $1,136 | 37.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 13 | 26 | $1,300 | $422.68 | 32.5% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 228 | 243 | $371,322 | $43,159 | 11.6% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 117 | 120 | $126,624 | $13,252 | 10.5% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 30 | 30 | $58,545 | $6,834 | 11.7% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 36 | 38 | $21,942 | $2,363 | 10.8% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 24 | 25 | $1,850 | $179.50 | 9.7% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 169 | 176 | $266,840 | $28,177 | 10.6% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 38 | 38 | $66,077 | $7,811 | 11.8% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 67 | 69 | $71,133 | $7,182 | 10.1% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 39 | 41 | $27,058 | $2,309 | 8.5% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 21 | 22 | $1,628 | $163.02 | 10.0% |
About Dr. William Downs, DO
Dr. William Downs, DO is a Emergency Medicine healthcare provider based in Long Branch, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801833132.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Downs, DO has received a total of $2,747 in payments from pharmaceutical and medical device companies, with $254.27 received in 2024. These payments were reported across 112 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($2,747).
As a Medicare-enrolled provider, Downs has provided services to 1,167 Medicare beneficiaries, totaling 1,225 services with total Medicare billing of $161,545. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Location Long Branch, NJ
- Active Since 06/02/2006
- Last Updated 04/14/2008
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1801833132
Products in Payments
- XARELTO (Drug) $1,389
- ANDEXXA (Biological) $252.08
- LOKELMA (Drug) $186.55
- ELIQUIS (Drug) $178.49
- Kcentra (Biological) $172.61
- Veklury (Drug) $157.93
- DALVANCE (Drug) $133.97
- EPIC VASCULAR (Device) $123.91
- CLEVIPREX (Drug) $33.93
- TE7 MAX (Device) $24.98
- OXBRYTA (Drug) $15.69
- XIFAXAN (Drug) $13.74
- NA (Device) $12.77
- Edarbi (Drug) $11.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Long Branch
Dinesh Shah, Md, MD
Emergency Medicine — Payments: $732.39
Emergency Medicine $732.39
Dr. Harisios Tjionas, D.o, D.O
Emergency Medicine — Payments: $592.25
Emergency Medicine $592.25
Catherine Hanlon, Md, MD
Emergency Medicine — Payments: $589.71
Emergency Medicine $589.71
Elizabeth Gilman, Md, MD
Emergency Medicine — Payments: $393.91
Emergency Medicine $393.91
Dr. Laura Snyder, Md, MD
Emergency Medicine — Payments: $264.96
Emergency Medicine $264.96
Michael Eagan, Md, MD
Emergency Medicine — Payments: $113.43
Emergency Medicine $113.43